Peptide Hubs
Retatrutide 10 mg
Retatrutide 10 mg – Multi-Agonist Peptide for Metabolic Research
Active Ingredient: Retatrutide
Manufacturer: Peptide Hubs
Pack Size: 2 mL Vial
Lab Report: View Results
$50.00
Shipping From:
International
U.S. Domestic
WHAT IS RETATRUTIDE 10 MG?
Retatrutide is a next-generation triple receptor agonist peptide that targets GLP-1, GIP, and glucagon receptors. This innovative compound is under investigation for its synergistic potential in promoting fat loss, appetite suppression, and metabolic regulation in research settings.
RESEARCH APPLICATIONS
- Obesity and bodyweight regulation models
- Enhanced insulin sensitivity and glucose control
- Lipid metabolism and thermogenic pathways
- Triple-receptor agonist comparative analysis
HOW RETATRUTIDE WORKS
By activating GLP-1, GIP, and glucagon receptors simultaneously, Retatrutide may improve glycemic control, enhance energy expenditure, and reduce appetite more effectively than single or dual agonist peptides. These properties make it a valuable tool in long-term metabolic research protocols.
RESEARCH DOSING PROTOCOL
- Common Research Dose: 2.5–10 mg per week
- Administration Route: Subcutaneous
- Research Duration: 6 to 12 weeks, depending on study design
STACKING OPTIONS IN METABOLIC RESEARCH
Retatrutide is often compared or studied alongside other weight management compounds:
- Tirzepatide – GIP/GLP-1 dual agonist
- Semaglutide – GLP-1 specific agonist
- Survodutide – GLP-1 + glucagon dual agonist
Lab Test Available
ORDERING & SHIPPING DETAILS
This peptide is available to order from our peptide source with U.S. domestic fulfillment. All peptides are intended for laboratory and research use only.
EXTERNAL REFERENCE
Learn more via Retatrutide on PubChem.
FAQ
What makes Retatrutide different from Semaglutide or Tirzepatide?
Retatrutide is a triple receptor agonist (GLP-1, GIP, and glucagon), whereas Semaglutide activates GLP-1 only, and Tirzepatide targets GLP-1 and GIP. Retatrutide is thought to offer additional thermogenic benefits due to glucagon activation.
Is Retatrutide approved for human use?
No. It is a research peptide intended strictly for laboratory experimentation and is not approved for human or veterinary consumption.
Can this be stacked with peptides like Cagrilintide?
Some labs explore combinations with peptides such as Cagrilintide for synergistic appetite and satiety pathways in experimental obesity models.
How should Retatrutide be stored?
Store the vial in a cool, dry place at 2–8°C. For long-term storage, freezing at -20°C is recommended. Reconstituted peptide should be used within a short window and kept refrigerated.
No reviews found
Please log in to write Retatrutide 10 mg review.
Related Offers
Lab Tested
Domestic & International
Buy 2 and get 1 of 'Retatrutide 10 mg' for FREE
Dragon Pharma, Europe
Retatrutide 10 mg – Advanced Weight Loss & Metabolic Support
Active Ingredient: Retatrutide
Manufacturer: Dragon Pharma
Pack Size: 2 mL Vial (10 mg, Lyophilized Powder)
Lab Report: View Results
$145.00
Domestic & International
Buy 3+ for $288.30 and save $65.10
Simplex Novonordisk, Turkey
Norditropin 45 IU – Advanced HGH Therapy in Cartridge Form
Active Ingredient: Human Growth Hormone (Somatropin)
Manufacturer: Novo Nordisk
Pack Size: 1 Cartridge (45 IU total)
$310.00
Lab Tested
Domestic & International
Buy 2 and get 1 of 'Selank 10 mg' for FREE
Dragon Pharma, Europe
Selank 10 mg – Nootropic Peptide for Mental Clarity & Anxiety Relief
Active Ingredient: Selank
Manufacturer: Dragon Pharma
Pack Size: 2 mL Vial (10 mg Lyophilized Powder)
Lab Report: View Results
$45.00
Lab Tested
Shipped USA Domestic
Dragon Pharma, Europe
BPC 157 5 mg – Advanced Healing & Recovery Peptide
Active Ingredient: Pentadecapeptide (BPC 157)
Manufacturer: Dragon Pharma
Form: Lyophilized Powder
Pack Size: 2 mL Vial (5 mg/vial)
Lab Report: View Results
$80.00
Shipped International
Buy 3+ for $51.15 and save $11.55
NovoNordisk, Turkey
Peptide Hormone
Raw Material: Insulin Aspart
Manufacturer: Novo Nordisk
Package: 5 Pens x 3 mL [100 IU/mL]
$55.00